News
MRFF backs UQ epilepsy research
UQ researchers have received $4.1 million from the Medical Research Future Fund to advance their research into epilepsy treatments made from spider venom proteins.
Led by Professor Ernst Wolvetang, the project aims to prove the safety and efficacy of venom-based drugs by testing them on lab-grown brain and heart organoids grown from the cells of epilepsy patients.
The research aims to pave the way for human clinical trials and to establish organoids as a tool that can be used to test experimental treatments and therapies.
The funding has been provided through the MRFF’s Stem Cell Therapies grant scheme.
Media contactUQ Communications
communications@uq.edu.au
+61 429 056 139
Related articles
How everyday household tasks impact relationships
The physical, cognitive and emotional loads of running a household should be recognised when examining the health of a couple’s relationship, research has found.
27 August 2026
Takeaway cups release microplastics into your coffee
Single-use paper cups used for takeaway coffee and other beverages release millions of microplastic particles when exposed to hot liquid, University of Queensland researchers have found.
27 August 2026